Platelet activation by alpha-thrombin is a receptor-mediated event

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Human platelets exhibit complex interactions with alpha-thrombin, a key enzyme in hemostasis.
• Understanding these interactions is crucial for elucidating platelet activation mechanisms.

Purpose of the Study:

• To characterize the binding sites of alpha-thrombin on human platelets.
• To investigate the differential binding and activation roles of modified thrombins (TLCK-thrombin and PPACK-thrombin).

Main Methods:

• Computer-assisted data analysis using LIGAND software to analyze binding isotherms.
• Platelet treatment with Serratia marcescens protease to probe binding site accessibility.
• Competition assays to assess the role of different binding sites in platelet activation.

Main Results:

• Human platelets display high (Kd 0.3 nM), moderate (Kd 10 nM), and low (Kd 3 microM) affinity binding sites for alpha-thrombin.
• PPACK-thrombin binds to the high-affinity site, while TLCK-thrombin does not; both bind to moderate and low-affinity sites.
• Serratia marcescens protease treatment eliminates high-affinity binding but preserves moderate-affinity binding.

Conclusions:

• Platelet activation by thrombin at low and moderate concentrations is receptor-mediated.
• Differential binding of modified thrombins explains their distinct effects on platelet activation.
• A model is proposed where PPACK-thrombin competes at high-affinity sites, while both compete at moderate-affinity sites.